Organoids and AI: Unlocking the Mysteries of Cancer Immune Evasion and Immunotherapy
Molecular Devices scientists Zhisong Tong, PhD, and Angeline Lim, PhD, collaborate on this piece for Biocompare exploring how organoids and AI are helping address two fundamental, longstanding questions: How do cancers evade the immune system, and how can we make cancer more vulnerable to immune attack? Read on to discover how patient-derived organoids (PDOs) and AI-driven data analysis are transforming our understanding of cancer immune evasion and immunotherapy.